Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
180 Life Sciences Corp
ATNFCurrent price
2.9 USD
-0.03 USD (-1.02%)
Last closed
2.93 USD
Company
180lifesciences.com
ISIN
US68236V1044
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
3 840 718 USD
Yield for 12 month
-62.30 %
1Y
3Y
5Y
10Y
15Y
ATNF
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren's Contracture; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, that focuses on alpha 7 nicotinic acetylcholine receptor. The company is headquartered in Palo Alto, California. Address: Building 4, Palo Alto, CA, United States, 94306
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
80 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+166 030 USD
Current Year
-105 675 USD
Last Year
-109 004 USD
Current Quarter
-23 981 USD
Last Quarter
-23 576 USD
Key Figures ATNF
1 year
3 years
5 years
10 years
EBITDA
-8 826 971 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-63.5 %
PEG Ratio
–
Return On Equity TTM
-398.58 %
Wall Street Target Price
80 USD
Revenue TTM
–
Book Value
-0.44 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-11.2 USD
Diluted Eps TTM
-11.2 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ATNF
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ATNF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:19
Payout Ratio
–
Last Split Date
28.02.2024
Dividend Date
–
Stock Valuation ATNF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
6.079
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.4596
Price Book MRQ
0.3608
Financials ATNF
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ATNF
For 52 weeks
1.16 USD
9.23 USD
50 Day MA
2.45 USD
Shares Short Prior Month
73 286
200 Day MA
2.46 USD
Short Ratio
1.25
Shares Short
78 662
Short Percent
7.72 %
BeatStart